Histotripsy: The Sound-Wave Therapy That Could Transform Cancer Care

What histotripsy is

The word histotripsy joins the Greek-derived terms for tissue (histo) and crushing (tripsy). It is a form of therapeutic focused ultrasound, but it works very differently from approaches that rely on heating tissue.

A treatment system sends brief, high-intensity ultrasound pulses through the skin and focuses them at a precisely selected point inside the body. At that focal point, the pulses create a dense cloud of microscopic bubbles in the fluid within tissue. The bubbles form, expand, and collapse extremely rapidly — a physical process called acoustic cavitation.

That bubble activity generates intense but highly localized mechanical forces. Cell membranes are disrupted, tumor tissue is fragmented into microscopic debris, and the body gradually clears the treated material through its normal biological processes.

Mechanical ablation, not burning

Most established local cancer treatments use one of a few strategies: surgery removes a tumor, radiation damages cancer cells with ionizing energy, radiofrequency and microwave ablation heat tissue until it dies, cryoablation freezes it, and chemical ablation injects a destructive substance into the lesion.

Histotripsy introduces another category: mechanical ablation by controlled cavitation. A simple analogy helps — thermal ablation is closer to cooking tissue; histotripsy is closer to using focused sound to produce a tiny, controlled, bubble-driven demolition zone inside it.

The treatment sequence

The clinical team first identifies the tumor and maps the planned treatment volume using ultrasound and other imaging. A multi-element transducer outside the body then directs energy so the strongest effect occurs at the focal target rather than along the entire beam path.

Short, high-amplitude pulses generate a confined cloud of microbubbles inside the target zone. The rapid bubble dynamics create shear forces and other mechanical effects that break apart tumor cells and soft-tissue architecture. Because the active bubble cloud is visible on ultrasound, treatment can be delivered with direct feedback.

Afterward, the treated area becomes a zone of fragmented, largely acellular material that the body gradually processes and clears.

Why the approach is different

Histotripsy's potential comes from a distinctive combination of properties. It is noninvasive — no incision, and no ablation needle passed through skin into the tumor. It is nonionizing and nonthermal, working primarily by mechanical disruption. It is image-guided, so clinicians can watch both the target and the cavitation activity during treatment. The effect is highly localized to the acoustic focus, and because no incision is required, the method may suit situations where repeated local treatment is useful. It is also compatible with combination therapy alongside immunotherapy, chemotherapy, or targeted drugs.

For tumors in anatomically challenging locations, these properties could eventually make treatment less invasive and more precise than many existing options.

The first clinical success: liver tumors

Histotripsy has crossed the most important line in medical development — from laboratory research into regulated clinical use. In October 2023, the U.S. Food and Drug Administration authorized marketing of the Edison Histotripsy System for noninvasive destruction of liver tumors, including unresectable liver tumors, making histotripsy the first FDA-authorized technology of its kind for that purpose.

The pivotal #HOPE4LIVER clinical program provided the foundation. In the early multicenter study, investigators reported technical success in 95% of treated lesions, and follow-up data reported encouraging local tumor-control outcomes at one year in selected treated liver tumors.

This matters because the liver is a frequent site of both primary cancer and metastases — from hepatocellular carcinoma, colorectal cancer, neuroendocrine tumors, breast cancer, melanoma, and others. Many patients cannot undergo major surgery, and some need local therapy repeatedly as new lesions emerge. For appropriately selected lesions, histotripsy offers a new possibility: destroy the target without placing a probe into the liver and without relying on heat.